Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Newly-listed BioNTech buys Neon to boost cell therapy assets

Newly-listed BioNTech buys Neon to boost cell therapy assets

who are not responding to treatment with checkpoint inhibitor drugs like Bristol-Myers Squibb’s Opdivo (nivolumab) and Merck &Co’s Keytruda (pembrolizumab).

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer A combination trial of Rubraca plus Bristol-Myers Squibb’s checkpoint inhibitor Opdivo (nivolumab) – called CheckMate 9KD – is also ongoing with initial results due later this year.

FDA starts priority review of BMS Opdivo/Yervoy in first-line NSCLC

FDA starts priority review of BMS Opdivo/Yervoy in first-line NSCLC A verdict is expected to be delivered by 15 May. Bristol-Myers Squibb’s marathon to get approval for its immuno-oncology drug Opdivo in first-line non-small cell lung

Nektar’s opioid analgesic slammed with FDA panel rejection

Nektar’s opioid analgesic slammed with FDA panel rejection The  Bristol-Myers Squibb-partnered CD122-biased agonist NKTR-214 is due to start two new phase 3 studies soon, with the partners working on investigating the drug in 20 indications

BMS expands collaboration with Nektar, sending shares soaring

BMS expands collaboration with Nektar, sending shares soaring Adds research programmes in an additional two cancer types. Bristol-Myers Squibb has expanded its development programme with Nektar, sending shares in the biotech soaring by nearly 20%. . ... Bristol-Myers Squibb and Nektar view bempeg as an important

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics